"10.1371_journal.pone.0037787","plos one","2012-05-25T00:00:00Z","Thomas Lundåsen; Eva-Marie Andersson; Michael Snaith; Helena Lindmark; Johanna Lundberg; Ann-Margret Östlund-Lindqvist; Bo Angelin; Mats Rudling","Karolinska Institute, Department of Endocrinology, Metabolism and Diabetes, Department of Medicine, and Molecular Nutrition Unit, Center for Biosciences, NOVUM, Karolinska University Hospital Huddinge, Stockholm, Sweden; Bioscience, AstraZeneca R&D, Mölndal, Sweden; Lead Generation, AstraZeneca R&D, Mölndal, Sweden; Transgenics and Comparative Genomics, at AstraZeneca R&D, Mölndal, Sweden","Conceived and designed the experiments: TL EMA MS HL AMÖL BA MR. Performed the experiments: TL EMA HL AMÖL BA MR. Analyzed the data: TL EMA MS HL JL AMÖL BA MR. Contributed reagents/materials/analysis tools: TL EMA MS HL AMÖL MR. Wrote the paper: TL EMA HL JL AMÖL BA MR.","BA and MR have for other studies received research grants from AstraZeneca and Albireo AB; BA has served as a board member of and is a shareholder in AstraZeneca PLC; EMA, HL, SS and A-MÖ-L are employees at AstraZeneca. MS and SS were previously employed by AstraZeneca; TL and JL have nothing to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","05","Thomas Lundåsen","TL",8,TRUE,7,6,8,7,TRUE,TRUE,FALSE,0,NA,FALSE
